[1]
R. Ruby, E. S. Arifin, and Charens, “The Curative Innovation of Novel Triple-Drug Compared to Double-Drug Regimen in Lymphatic Filariasis: A Systematic Review”, IJTID, vol. 10, no. 3, pp. 165–175, Dec. 2022.